Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Nivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible...

Dr Michiel Simon van der Heijden - Netherlands Cancer Institute, Amsterdam...

Nivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible metastatic urothelial carcinoma ( Dr Michiel Simon van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer

Prof Sven Mahner - Ludwig Maximilian University of Munich, Munich, Germany

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer ( Prof Sven Mahner - Ludwig Maximilian University of Munich, Munich, Germany )

New MOAs in prostate cancer treatment - what’s next?

Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini

New MOAs in prostate cancer treatment - what’s next? ( Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini )

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers

Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers ( Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil )

QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBC

Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany

QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBC ( Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany )

Long-term infusion of dinutuximab beta improves survival in high-risk...

Dr Ruth Ladenstein - St. Anna Children's Hospital, Vienna, Austria

Long-term infusion of dinutuximab beta improves survival in high-risk neuroblastoma ( Dr Ruth Ladenstein - St. Anna Children's Hospital, Vienna, Austria )

Relacorilant plus chemo improves PFS and OS vs chemo alone in platinum...

Dr Brian Slomovitz - Mount Sinai Medical Center, Miami Beach, USA

Relacorilant plus chemo improves PFS and OS vs chemo alone in platinum-resistant ovarian cancer ( Dr Brian Slomovitz - Mount Sinai Medical Center, Miami Beach, USA )

Barriers to global oncology clinical trial participation in sub-Saharan Africa

Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA

Barriers to global oncology clinical trial participation in sub-Saharan Africa ( Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA )

Social determinants and survival outcomes in early-onset colorectal cancer in...

Dr Jessica Paulus - Ontada, Boston, USA

Social determinants and survival outcomes in early-onset colorectal cancer in the US ( Dr Jessica Paulus - Ontada, Boston, USA )

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers...

Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora...

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform ( Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA )

Molecular assay may help identify NSCLC patients who could benefit from...

Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy ( Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA )

GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related...

Dr Lucas A Mavromatis - NYU Grossman School of Medicine, New York, USA

GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabetics ( Dr Lucas A Mavromatis - NYU Grossman School of Medicine, New York, USA )

More from ecancer